Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.

Liver international : official journal of the International Association for the Study of the Liver - 1 Jul 2012

Huang Jee-Fu, Yu Ming-Lung, Huang Chung-Feng, Juo Suh-Hang Hank, Dai Chia-Yen, Hsieh Ming-Yen, Hou Nei-Jen, Yeh Ming-Lun, Hsieh Meng-Hsuan, Yang Jeng-Fu, Lin Zu-Yau, Chen Shinn-Chern, Shin Shyi-Jang, Chuang Wan-Long

Abstract excerpt

BACKGROUND/AIMS: Pre-diabetes is a risk factor for type 2 diabetes mellitus (DM) development. This study aimed to elucidate the impact of treatment response on sequential changes in glucose abnormalities in pre-diabetic chronic hepatitis C (CHC) patients. METHODS: Chronic Hepatitis C patients with a baseline haemoglobin A1C (A1C) range 5.7-6.4% who achieved 80/80/80 adherence were prospectively recruited. All...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycated Hemoglobin
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Interferons

Share to Interleukins

Share to Polyethylene Glycols

Share to Prediabetic State

Share to Ribavirin

Source

Identifiers

PMID: 22356575
DOI: 10.1111/j.1478-3231.2012.02771.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.PMID 22356575Read ↗

The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents.Semantic proximity Read ↗

Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir.Semantic proximity Read ↗

Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4.Semantic proximity Read ↗

Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection.Semantic proximity Read ↗

Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Clinical impact of the new criteria for the diagnosis of diabetes mellitus.Semantic proximity Read ↗

Risk factors for Type 2 Diabetes Mellitus in Chronic Hepatitis C Virus-Infected Patients: A Retrospective Cohort Study in Southern ChinaSemantic proximity Read ↗

Prevalence of abnormal glycometabolism in treatment-naive patients with hepatitis C virus infection in a Chinese Han population.Semantic proximity Read ↗

Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection.Semantic proximity Read ↗

Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients.Semantic proximity Read ↗

The effect of dulaglutide on glycated hemoglobin is associated with PNPLA3 Ι148Μ gene polymorphism in patients with type 2 diabetes mellitus.Semantic proximity Read ↗

Effects of hepatitis C virus genotypes and viral load on glucose and lipid metabolism after sustained virological response with direct-acting antivirals.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.